Friday - October 17, 2025
Goodwin Represents Orbital Therapeutics in $1.5 Billion Acquisition by Bristol Myers Squibb
October 16, 2025
BOSTON, Massachusetts, Oct. 16 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Represents Orbital Therapeutics in $1.5 Billion Acquisition by Bristol Myers Squibb

*

The Life Sciences team represented Orbital Therapeutics ("Orbital") on a definitive agreement under which Bristol Myers Squibb (NYSE: BMY, "BMS") will acquire Orbital. The acquisition includes Orbital's lead . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products